Topic Schizophrenia Discover the archives of schizophrenia and related articles Schizophrenia 20 Apr, 2022 Read Time: 3 mins Congress highlights Article Do early intervention services impact long-term outcomes in patients with psychosis? Early intervention services (EIS) specifically designed to meet the needs of patients with... Schizophrenia 12 Apr, 2022 Read Time: 2 mins Congress highlights Article Are prior mood disorders more important than positive symptoms for predicting psychosis? Predicting which individuals will develop a psychotic disorder or transition from high risk of... Depression, Schizophrenia 14 Oct, 2021 Read Time: 5 mins Satellite symposium Beyond symptoms: the importance of hearing the patient’s voice in measuring life engagement Historically, the definition of mental illness has been diagnosis-focused, with successful treatment... Mental Health 06 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 4 — October 5th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Mental Health 05 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 3 — October 4th Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Schizophrenia 04 Oct, 2021 Read Time: 4 mins Satellite symposium Small steps for big impact in treatment of schizophrenia Functional recovery is an important goal in treating schizophrenia, but one that can be hard to... Mental Health 04 Oct, 2021 Read Time: 4 mins Congress highlights Highlights from ECNP 2021 — Day 2 — October 3rd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Mental Health 03 Oct, 2021 Read Time: 3 mins Congress highlights Highlights from ECNP 2021 — Day 1 — October 2nd Welcome to Progress in Mind’s live coverage of ECNP 2021. This 34th Congress of the European College... Schizophrenia 06 Sep, 2021 Read Time: 3 mins Congress highlights The link between myelination, psychosis and antipsychotics The hypothesis that myelin alterations play a critical role in the development of psychosis is... Depression, Schizophrenia 06 Sep, 2021 Read Time: 2 mins Congress highlights Quarantines, lockdowns, and social isolation: What are we brewing? The COVID-19 pandemic continues to impact well-being across the globe. Lockdowns, quarantine, and... Schizophrenia 11 Aug, 2021 Read Time: 4 mins Article Improving long-term outcomes in schizophrenia — translating evidence into practice The long-term goals of treatment to optimize outcomes for patients with schizophrenia are relapse... Schizophrenia 20 Jul, 2021 Read Time: 3 mins Satellite symposium Long-acting injectable antipsychotics in clinical practice For patients with schizophrenia, appropriate use of long-acting injectable antipsychotics lowers the... Schizophrenia 20 Jul, 2021 Read Time: 2 mins Article ‘A Stitch in Time – Managing Schizophrenia Effectively Long Term’ The treatment of chronic illnesses commonly includes the long-term use of pharmacotherapy. However,... Schizophrenia 12 Apr, 2021 Read Time: 3 mins Satellite symposium Long-acting injectables together with medical team training may facilitate functional recovery Early use of long-acting injectables together with targeted staff training may facilitate short- and... Depression, Schizophrenia 17 Mar, 2021 Read Time: 3 mins Satellite symposium Patient engagement: A new concept in patient-centric functional recovery Patient engagement – a concept that includes life fulfillment, well-being and participation in daily... Schizophrenia 17 Mar, 2021 Read Time: 3 mins Satellite symposium Life engagement is focus of patient-centered functional recovery Enhancing engagement with life is a key target of treatment in schizophrenia and extends beyond... Schizophrenia 08 Mar, 2021 Read Time: 2 mins Satellite symposium Early onset schizophrenia needs patient-specific management Early diagnosis and effective, well-tolerated treatment of early-onset schizophrenia are crucial to... Depression, Schizophrenia 19 Feb, 2021 Read Time: 4 mins Congress highlights Why do we need new treatments for major depressive disorder and schizophrenia? Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as... Schizophrenia 14 Feb, 2021 Read Time: 6 mins Congress highlights Finding the sweet spot for pharmacotherapy in schizophrenia Over recent years, the goals in the management of patients with schizophrenia have evolved from... Schizophrenia 11 Feb, 2021 Read Time: 1 min Congress highlights Long-acting injectables – functioning and compliance studies Two posters presented during SIRS 2019 suggest that use of long-acting injectable (LAI) antipsychotic... Schizophrenia 03 Feb, 2021 Read Time: 3 mins Satellite symposium Balancing efficacy and tolerability to personalize treatment choices in schizophrenia The Precision Medicine Initiative was launched in 2015 in the United States. This approach to disease... Schizophrenia 02 Feb, 2021 Read Time: 3 mins Satellite symposium Why use of long acting injectables is an urgent issue Long acting injectable antipsychotics are often withheld until later stages of schizophrenia, but... Schizophrenia 02 Feb, 2021 Read Time: 2 mins Satellite symposium The importance of patient functioning in schizophrenia Speakers at this satellite symposium discussed the importance of addressing not just the symptoms of... Schizophrenia 18 Jan, 2021 Podcast Do long-acting injectable antipsychotics have a role in early-phase schizophrenia? Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes. This... Mental Health 08 Jan, 2021 Podcast Digital technologies - an opportunity to achieve Mental Health for All Digital technologies have the potential to transform the theme for World Mental Health Day 2020 —... Schizophrenia 05 Jan, 2021 Read Time: 3 mins Congress highlights Can deep brain stimulation treat schizophrenia? Widespread successful use of deep brain stimulation (DBS) to treat neurological conditions, such as... Schizophrenia 22 Nov, 2020 Read Time: 2 mins Congress highlights Negative symptoms improved by early intervention New EPA guidelines on the diagnosis and management of negative symptoms should help draw attention to... Schizophrenia 05 Nov, 2020 Read Time: 3 mins Satellite symposium Early stage schizophrenia and the road to recovery During this symposium, Professor Nadja Marić, Serbia, discussed the patient’s journey through... Schizophrenia 19 Oct, 2020 Read Time: 3 mins Satellite symposium Engaging patients with schizophrenia in decision-making to improve outcomes Medication adherence is a challenge for many patients, especially with chronic diseases, such as... Schizophrenia 16 Oct, 2020 Read Time: 2 mins Satellite symposium Seize opportunities to improve long-term outcome Given the strong evidence that long acting treatment improves functional outcomes, we need to be more... Depression, Schizophrenia 16 Oct, 2020 Read Time: 5 mins Congress highlights Lifestyle, the gut, and mental health Interventions to lower the risk for cardiovascular disease and metabolic syndrome, correction of... Mental Health 02 Oct, 2020 Read Time: 3 mins Congress highlights Why is greater investment key to better mental health? Every individual with a mental health disorder has a unique experience. Understanding this... Mental Health 01 Oct, 2020 Read Time: 3 mins Article No health without mental health The 10–25-year lower life expectancy of people with severe mental health disorders compared to the... Mental Health 16 Sep, 2020 Read Time: 2 mins Article World Mental Health Day 2020 — addressing stigma and discrimination to achieve Mental Health for All The theme for World Mental Health Day 2020 is Mental Health for All: Greater Investment, Greater... Schizophrenia 13 Sep, 2020 Read Time: 3 mins Satellite symposium Do long-acting injectable antipsychotics have a role in early-phase schizophrenia? Early intervention and continuous treatment in schizophrenia are key to ensuring good outcomes. This... Mental Health 05 Sep, 2020 Read Time: 2 mins Article Digital technologies — an opportunity to achieve Mental Health for All Digital technologies have the potential to transform the theme for World Mental Health Day 2020 —... Schizophrenia 28 Jul, 2020 Read Time: 3 mins Article Are antipsychotics needed for the long-term treatment of schizophrenia? ‘Do we need antipsychotics for the long-term treatment of schizophrenia?’ was the title of this... Schizophrenia 28 Jul, 2020 Read Time: 3 mins Congress highlights Real world study casts new light on potential of polypharmacy The fact that 20-25% of patients with schizophrenia are treated with more than one antipsychotic1... Schizophrenia 05 Jul, 2020 Read Time: 3 mins Congress highlights Addressing the unmet need of cognitive dysfunction in schizophrenia Metacognition needs to be an important component of cognitive remediation therapy (CRT) to... Schizophrenia 22 May, 2020 Read Time: 3 mins Article Making sense of exercise in schizophrenia - No sweat! Clinicians are well aware that cardiorespiratory fitness and cognition are related in schizophrenia.... Schizophrenia 22 May, 2020 What is Schizophrenia? Schizophrenia 15 May, 2020 Read Time: 2 mins Article Taper or maintain antipsychotics in schizophrenia? Taper or maintain? This is a central dilemma surrounding use of antipsychotic medication in patients... Schizophrenia 12 May, 2020 Read Time: 3 mins Article Negative symptoms in schizophrenia – get thee gone! Negative symptoms in schizophrenia – faculties apparently lacking or somehow diminished – have long... Schizophrenia 11 May, 2020 Read Time: 4 mins Article COVID-19: Pandemic brings challenge and opportunity for people with schizophrenia (including telemedicine!) The COVID-19 pandemic risks exacerbating symptoms in people prone to experience reality in unusual... Mental Health 06 Apr, 2020 Read Time: 2 mins Article COVID-19: Practical support for mental health in time of crisis Many people with mental health diseases will experience additional emotional distress when faced with... Schizophrenia 25 Mar, 2020 Should we challenge the way we assess functioning? Mental Health 22 Mar, 2020 What role should patients play in treatment decision making? Mental Health 19 Mar, 2020 Read Time: 3 mins Congress highlights Motivating strategies to fight stigma Stigma means exclusion, and is the largest barrier preventing people from seeking mental healthcare,... Depression, Schizophrenia 12 Mar, 2020 Read Time: 1 min Congress highlights Measurement-based care: How can we improve outcomes for patients with depression and schizophrenia Measurement-based care (MBC) can improve outcomes and reduce health disparities for serious mental... Mental Health 02 Mar, 2020 Read Time: 3 mins Congress highlights Do men and women experience psychiatric disorders differently? There are several known epidemiological differences between the genders in psychiatric disorders.... Schizophrenia 26 Feb, 2020 Read Time: 3 mins Article The neurobiology of conversion to psychosis – emerging findings from the SHARP study The clinical high risk (CHR) phase of schizophrenia when cognitive and social functioning begin to... Mental Health 14 Feb, 2020 Read Time: 3 mins Article Real-world evidence — raising organizational fluency through interactive learning techniques Real-world evidence (RWE) demonstrates long-term effectiveness and safety beyond the efficacy and... Schizophrenia 14 Feb, 2020 Read Time: 3 mins Congress highlights Core components of the Coordinated Specialty Care model for first-episode psychosis The Coordinated Specialty Care (CSC) model for first-episode psychosis (FEP) is an evidence-based... Schizophrenia 31 Jan, 2020 Read Time: 2 mins Article Social and cognitive interventions that improve outcomes for patients with psychosis A 3-month critical time intervention service involving social workers and peer specialists to connect... Mental Health 23 Jan, 2020 Read Time: 4 mins Congress highlights How are genes involved in tailoring psychiatric treatment? Psychiatrists need an understanding of genome-wide association studies (GWAS), pharmacogenomics, and... Mental Health 14 Nov, 2019 Read Time: 3 mins Congress highlights Can blue-depleted light decrease duration of psychiatric hospitalization? Novel light and sensor technologies have been installed in a new acute psychiatric unit in Norway to... Mental Health 30 Oct, 2019 Read Time: 3 mins Congress highlights The new technologies transforming psychiatric practice and patient outcomes Data-driven approaches to psychiatric diagnosis and practice fueled by the abundance of information... Schizophrenia 08 Oct, 2019 Read Time: 5 mins Satellite symposium Are relapse prevention and functioning sufficiently prioritized in the treatment of schizophrenia? Improving adherence and reducing rates of relapse and rehospitalization are of paramount importance... Schizophrenia 07 Oct, 2019 Video #8: Initiation of long-acting injectable antipsychotic treatment in patients with schizophrenia Schizophrenia 07 Oct, 2019 Video #8: Initiation of long-acting injectable antipsychotic treatment in patients with schizophrenia - GIDI test Schizophrenia 30 Sep, 2019 Video #7: Long-acting injectable antipsychotics in the treatment plan of patients with schizophrenia Schizophrenia 25 Sep, 2019 Read Time: 5 mins Satellite symposium Treatment outcomes in schizophrenia – what matters to patients? Schizophrenia treatment has moved from mainly addressing relapse prevention and symptom suppression,... Schizophrenia 25 Sep, 2019 Read Time: 4 mins Congress highlights Early psychosis intervention works, but can we move to prevention? Many individuals at high familial risk of schizophrenia show cognitive and social impairment well... Schizophrenia 25 Sep, 2019 Video #6: Which patients are best suited for long-acting injectable antipsychotics? Schizophrenia 20 Sep, 2019 Read Time: 4 mins Congress highlights Can we be bothered about apathy? Approaching negative symptoms in schizophrenia There has been an increased interest in research for the negative symptoms of schizophrenia over the... Schizophrenia 17 Sep, 2019 Video #5: Early intervention in schizophrenia is key for the long-term prognosis of the disease Schizophrenia 10 Sep, 2019 Video #4: Discussing the benefit of long-acting injectable antipsychotics with patients and carers Depression, Schizophrenia 03 Sep, 2019 Video #3: Shared decision-making and therapeutic alliance in schizophrenia Schizophrenia 29 Aug, 2019 Video #2: Patients at the center Schizophrenia 26 Aug, 2019 Read Time: 3 mins Article LAIs: old, classic, vintage or valuable? Professor Dana Niehaus, a psychiatrist at Stikland Hospital recently shared insights around the... Schizophrenia 20 Aug, 2019 Video #1: Offering long-acting injectable antipsychotics to patients with schizophrenia Mental Health 20 Aug, 2019 Read Time: 3 mins Congress highlights Beyond the guidelines: Precision Medicine Despite the attractiveness of precision medicine (PM) for providing personalized patient management,... Mental Health 04 Jun, 2019 Read Time: 3 mins Congress highlights A public invitation to view and comment on pre-final APA schizophrenia guideline statements Many guidelines exist worldwide on how best to manage psychiatric illnesses, but we never see two... Mental Health 04 Jun, 2019 Read Time: 3 mins Congress highlights What is the role of inflammation in the pathophysiology of mood disorders? Evidence supporting a role for inflammation and pro-inflammatory mediators in the pathophysiology and... Schizophrenia 24 May, 2019 Read Time: 4 mins Congress highlights Deconstructing schizophrenia – constructing new paradigms for discovery Schizophrenia is a heterogeneous disorder rather than a specific condition, William Carpenter,... Schizophrenia 22 May, 2019 Read Time: 4 mins Congress highlights Early detection and intervention in psychosis – where are we now? Many of those experiencing first-episode psychosis achieve clinical remission, but often with poor... Schizophrenia 14 Apr, 2019 Read Time: 4 mins Congress highlights Ethics of psychosis prevention – Could we? Should we? The SIRS Ethics Committee inaugurated the first of its annual symposia at SIRS 2019 to discuss the... Mental Health 10 Apr, 2019 Read Time: 4 mins Congress highlights Psychiatrist and patient partnership encourages trust and effective care We have so many shared objectives – notably ensuring adequate resources are given to mental health –... Mental Health 10 Apr, 2019 Read Time: 4 mins Congress highlights Potential new targets in depression and schizophrenia – learnings from obesity and exercise Weight loss and exercise increase benefit for mental health, but are difficult to achieve. The... Schizophrenia 08 Apr, 2019 Read Time: 3 mins Congress highlights Biomarkers - the Future of Diagnosis in Psychiatry? Diagnosis of psychiatric disorders currently depends on clinical criteria. In the future the hope is... Mental Health 22 Feb, 2019 Read Time: 3 mins Congress highlights Developments in disease understanding aid treatment innovation Instead of assigning patients with psychosis to diagnostic categories, we might concentrate on the... Schizophrenia 12 Feb, 2019 Read Time: 4 mins Article Complementary approaches for improving outcomes in first-episode psychosis Early intervention (EI) services are designed to improve outcomes in patients with first episode... Bipolar, Schizophrenia 11 Feb, 2019 Read Time: 3 mins Congress highlights Reconceptualizing psychosis based on biomarker analysis – personalized therapy to prevent disease progression When an extensive biomarker study characterizing diverse aspects of brain function unexpectedly... Schizophrenia 06 Feb, 2019 Read Time: 4 mins Congress highlights Tackling the elephant in the room: non-adherence in schizophrenia The challenges and consequences of non-adherence to treatment in schizophrenia, and some novel ways... Mental Health 04 Feb, 2019 Read Time: 3 mins Article Train, test, predict: Using big data and machine learning in psychiatry Introduction of biomarkers for diagnosis and treatment of psychiatric diseases into routine clinical... Schizophrenia 02 Feb, 2019 Read Time: 3 mins Congress highlights Investing in recovery – translating intervention into action Worldwide, recovery - defined by the presenter David McDaid, London, UK as the ability of affected... Schizophrenia 31 Jan, 2019 Read Time: 4 mins Article Changing the course of schizophrenia: biology, psychology and livelihood How to manage and mitigate some long-term problems associated with schizophrenia, and improve... Schizophrenia 22 Jan, 2019 Read Time: 4 mins Article Future of schizophrenia treatment: Where do we go now? Over the next decade, the outcomes for patients with schizophrenia should improve considerably,... Depression, Schizophrenia 14 Jan, 2019 Read Time: 2 mins Article Can new technologies address old problems in mental health treatment? Depression, Schizophrenia 14 Jan, 2019 Read Time: 6 mins Article ICD-11 – fielding for diagnostic success In 2018, the World Health Organization (WHO) will release two important documents, both of which... Mental Health 14 Jan, 2019 Read Time: 3 mins Congress highlights Mutual benefits: Public–Private Partnerships in CNS Research Public–Private Partnerships are being developed worldwide to facilitate collaboration between... Bipolar, Schizophrenia 14 Jan, 2019 Read Time: 3 mins Article Highlighted studies in psychosis New light cast on links between mental illness and creativity; inflammatory pathways that may be... Bipolar, Schizophrenia 29 Oct, 2018 Read Time: 3 mins Congress highlights Making the first-episode the last: Mitigating stigma in severe mental illnesses Internalized stigma is common among people with severe mental illness, and is associated with a... Depression, Schizophrenia 19 Jun, 2018 Read Time: 4 mins Congress highlights Why do we need new treatments for major depressive disorder and schizophrenia? Atypical antipsychotics are the mainstay of treatment for schizophrenia and a therapeutic option as... Depression, Schizophrenia 18 May, 2018 Read Time: 4 mins Article Stigma – time to change attitudes Stigma. During a symposium at this year’s EPA, four specialists advocated various approaches to... Schizophrenia 15 May, 2018 Read Time: 3 mins Congress highlights Treatment-resistant schizophrenia and the impact on caregivers: A focus group study Treatment-resistant schizophrenia (TRS), clinically defined as failure to respond to two trials of... Load More Most Popular Schizophrenia 18 Jan, 2021 Do long-acting injectable antipsychotics have a role in early-phase schizophrenia? Depression, Schizophrenia 14 Oct, 2021 Beyond symptoms: the importance of hearing the patient’s voice in measuring life engagement Schizophrenia 26 Apr, 2018 Accentuate the negative: drawing attention to negative symptoms in schizophrenia Depression, Bipolar, Schizophrenia 09 May, 2018 Disclosure can create a virtuous circle as solidarity replaces stigma Alcohol Dependence, PTSD, Depression, Bipolar, Schizophrenia 02 Oct, 2020 Why is greater investment key to better mental health?
